Hyperglycemia and Acute Coronary Syndrome. A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition， Physical Activity， and Metabolism需谨记此科学声明中的以下重.....
Hopital Bichat， Service de Diabetologie et d"Endocrinologie， Paris， France. michel.marre@bch.ap-hop-paris.fr OBJECTIVES: To test whether microalbuminuria in patients with type 2 diabetes and hypertension is.....
The FIELD study investigators* SummaryBackground： Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease， partly owing to dyslipidaemia， which can be amenable to fibr.....
Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however， some components of the metabolic syndrome are worsened by some β-blockers.Ob.....
N Engl J Med 2005; 352: 341-350 Solomon Tesfaye， M.D.， Nish Chaturvedi， M.D.， Simon E.M. Eaton， D.M.， John D. Ward， M.D.， Christos Manes， M.D.， Constantin Ionescu-Tirgoviste， M.D.， Danie.....
Angiology. 2003 Nov-Dec;54(6):679-90. Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus.( GREACE) Athy.....
Lancet. 2004 Aug 21;364(9435):685-96. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-co.....
关注公众号
安卓客户端
